Somatic activating mutations in MAP2K1 cause melorheostosis.

about

Somatic activating mutations in MAP2K1 cause melorheostosis.

Item

http://www.wikidata.org/entity/Q55362635

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Somatic activating mutations in MAP2K1 cause melorheostosis.

@en

Somatic activating mutations in MAP2K1 cause melorheostosis.

@nl

type

Item

label

Somatic activating mutations in MAP2K1 cause melorheostosis.

@en

Somatic activating mutations in MAP2K1 cause melorheostosis.

@nl

prefLabel

Somatic activating mutations in MAP2K1 cause melorheostosis.

@en

Somatic activating mutations in MAP2K1 cause melorheostosis.

@nl

P1476

Somatic activating mutations in MAP2K1 cause melorheostosis.

@en

P2093

Aleksandra Ivovic

http://www.w3.org/2001/XMLSchema#string

Edward W Cowen

http://www.w3.org/2001/XMLSchema#string

Eileen Lange

http://www.w3.org/2001/XMLSchema#string

Eric P Hanson

http://www.w3.org/2001/XMLSchema#string

Heeseog Kang

http://www.w3.org/2001/XMLSchema#string

James Katz

http://www.w3.org/2001/XMLSchema#string

Joan C Marini

http://www.w3.org/2001/XMLSchema#string

Klaus Klaushofer

http://www.w3.org/2001/XMLSchema#string

Paul Roschger

http://www.w3.org/2001/XMLSchema#string

Richard M Siegel

http://www.w3.org/2001/XMLSchema#string

P2860

Biology of RANK, RANKL, and osteoprotegerin

NIH Image to ImageJ: 25 years of image analysis

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein

Analysis of protein-coding genetic variation in 60,706 humans

Crystal structures of MEK1 binary and ternary complexes with nucleotides and inhibitors

Deactivating germline mutations in LEMD3 cause osteopoikilosis and Buschke-Ollendorff syndrome, but not sporadic melorheostosis

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis

Normative data for iliac bone histomorphometry in growing children.

P2888

s41467-018-03720-z

P304

1390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41467-018-03720-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

N Fratzl-Zelman

Francoise Meylan

Smita Jha

P577

2018-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103226601

http://www.w3.org/2001/XMLSchema#string

P698

29643386

http://www.w3.org/2001/XMLSchema#string

P932

5895796

http://www.w3.org/2001/XMLSchema#string